← Open Payments lookup

CASSANDRA ROACH: Open Payments

NPI 1790552784 · EMPORIA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$254 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $190 · 2025 $254

Food & beverage: $254
CompanyPaymentsAmount
Amgen Inc.2$39
ABBVIE INC.2$37
AstraZeneca Pharmaceuticals LP2$36
GlaxoSmithKline, LLC.2$34
Alkermes, Inc.2$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$18
E.R. Squibb & Sons, L.L.C.1$17
Novo Nordisk Inc1$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14
Corium, LLC1$12

Products named: OTEZLA, ARISTADA, AIRSUPRA, QULIPTA, XIFAXAN, VRAYLAR, BEXSERO, COBENFY.

Industry payments across KS — which companies pay providers there.